Cooper took a $24.4 million impairment charge in the second quarter on the intangible assets it acquired in 2016 from carrier screening firm Recombine.
According to John Zhang, founder and CEO of the New Hope Fertility Center, universal PGS will likely increase success rates of IVF further.
A study by researchers in Italy found that preimplantation genetic diagnosis and screening combined led to more successful pregnancies per transfer but fewer women had embryos transferred.
The genetic diagnostics firm has developed an NGS-based test that combines PGS, PGD, and informativity testing, and presented initial results at a recent conference.
The team built on a previous approach that used single-cell sequencing to screen for chromosomal abnormalities in embryos from couples undergoing IVF.
The firm plans to incorporate mtDNA analysis into its preimplantation genetic screening services this month.
The method could have future applications in preimplantation genetic diagnosis and circulating tumor cell analysis.
RHS recently acquired an Arrayjet Marathon instrument to produce EmbryoCellect, which competes with PGS kits sold by Illumina, Agilent Technologies, OGT, and others.
The company's goal is to transition from a one-test provider to a full-service genetic testing company in the reproductive health and potentially other markets.
The FAST-SeqS test screens embryos for chromosomal aneuploidies prior to implantation in an in vitro fertilization setting.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.